semaglutide california ban update just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in States cracking down on compounding

[45] Healthcare providers should exercise caution when prescribing concurrent CNS depressants and may need to adjust dosages or implement enhanced monitoring strategies

Traynelis SF, et al

Given the vital role of the gut microbiome in glucose homeostasis, we hypothesize that statin utilization may contribute to the gut microbiome dysbiosis, which potentially affects circulating metabolites and host glucose homeostasis

The New England Journal of Medicine, 389 (24), 22212232

Adult *AB liver was removed and fixed for identical tissue processing (Gupta and Mullins, Drug treatments Neomycin (10 mg/mL) and gentamicin (50 mg/mL) solutions (Sigma-Aldrich